These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12411755)

  • 1. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation.
    de Sévaux RG; Hoitsma AJ; van Hoof HJ; Corstens FJ; Wetzels JF
    Nephron Clin Pract; 2003 Jan; 93(1):C21-8. PubMed ID: 12411755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study.
    De Sévaux RG; Hoitsma AJ; Corstens FH; Wetzels JF
    J Am Soc Nephrol; 2002 Jun; 13(6):1608-14. PubMed ID: 12039990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
    Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
    Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
    J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential changes of biochemical bone parameters after kidney transplantation.
    Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
    Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
    Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martínez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 2001 Feb; 68(2):83-6. PubMed ID: 11310351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of lumbar bone mineral density in the late course after kidney transplantation.
    Brandenburg VM; Ketteler M; Fassbender WJ; Heussen N; Freuding T; Floege J; Ittel TH
    Am J Kidney Dis; 2002 Nov; 40(5):1066-74. PubMed ID: 12407653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation.
    Scolapio JS; DeArment J; Hurley DL; Romano M; Harnois D; Weigand SD
    JPEN J Parenter Enteral Nutr; 2003; 27(6):427-32. PubMed ID: 14621125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
    Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
    Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation.
    Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D
    Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation.
    Briner VA; Thiel G; Monier-Faugere MC; Bognar B; Landmann J; Kamber V; Malluche HH
    Transplantation; 1995 May; 59(10):1393-400. PubMed ID: 7770924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of bone disease at 2 years after transplantation: a single-center study.
    Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation.
    Thiébaud D; Krieg MA; Gillard-Berguer D; Jacquet AF; Goy JJ; Burckhardt P
    Eur J Clin Invest; 1996 Jul; 26(7):549-55. PubMed ID: 8864416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
    Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
    Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.